Zynex Newsroom

RBC Capital Maintains Zynex(ZYXI.US) With Buy Rating, Maintains Target Price $11

Futu NewsOct 25 20:36

Zynex Analyst Ratings

BenzingaOct 25 19:19

H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Raises Target Price to $17

Futu NewsOct 25 18:34

Zynex's Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating

TipRanksOct 25 18:20

Zynex Is Maintained at Outperform by RBC Capital

Dow JonesOct 9 03:09

RBC Capital Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $11

Futu NewsOct 8 20:31

Northland Securities Initiates Zynex(ZYXI.US) With Buy Rating, Announces Target Price $12.5

Futu NewsSep 18 08:31

Zynex Analyst Ratings

BenzingaSep 5 01:10

HC Wainwright & Co. Reiterates Buy on Zynex, Maintains $16 Price Target

BenzingaSep 5 01:09

H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 4 23:31

Buy Rating Affirmed for Zynex on FDA Clearance and Solid Growth Prospects

TipRanksSep 4 23:07

Zynex Price Target Cut to $12.00/Share From $15.00 by RBC Capital

Dow JonesJul 26 22:55

Zynex Analyst Ratings

BenzingaJul 26 19:55

RBC Capital Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $12

Futu NewsJul 26 19:37

Analysts Have Conflicting Sentiments on These Healthcare Companies: Morphic Holding (MORF), Pyxis Oncology (PYXS) and Zynex (ZYXI)

TipRanksJul 26 18:58

H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $16

Futu NewsJul 26 18:31

Buy Rating Affirmed for Zynex Amid Growth and Strategic Innovations

TipRanksJul 26 18:22

Zynex Analyst Ratings

BenzingaJun 14 22:09

RBC Capital Reiterates Outperform on Zynex, Maintains $15 Price Target

BenzingaJun 14 22:09

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Zynex (ZYXI)

TipRanksMay 1 18:50